Abstract P092: A novel approach to target drug-resistance in thyroid cancer by regulating Annexin 7 (ANXA7)/p21 axis

MLA

Surya Radhakrishnan, et al. “Abstract P092: A Novel Approach to Target Drug-Resistance in Thyroid Cancer by Regulating Annexin 7 (ANXA7)/P21 Axis.” Molecular Cancer Therapeutics, vol. 20, Dec. 2021, p. P092. EBSCOhost, https://doi.org/10.1158/1535-7163.targ-21-p092.

APA

Surya Radhakrishnan, Alakesh Bera, Narayanan Puthillathu, Nahbuma Gana, Madhan Subramanian, Eric Russ, Anubhuti Paria, Swarnarup Paria, Stephen Rothwell, Harvey B. Pollard, & Meera Srivastava. (2021). Abstract P092: A novel approach to target drug-resistance in thyroid cancer by regulating Annexin 7 (ANXA7)/p21 axis. Molecular Cancer Therapeutics, 20, P092. https://doi.org/10.1158/1535-7163.targ-21-p092

Chicago

Surya Radhakrishnan, Alakesh Bera, Narayanan Puthillathu, Nahbuma Gana, Madhan Subramanian, Eric Russ, Anubhuti Paria, et al. 2021. “Abstract P092: A Novel Approach to Target Drug-Resistance in Thyroid Cancer by Regulating Annexin 7 (ANXA7)/P21 Axis.” Molecular Cancer Therapeutics 20 (December): P092. doi:10.1158/1535-7163.targ-21-p092.